NASDAQ:SERA

Sera Prognostics (SERA) Stock Price, News & Analysis

Sera Prognostics logo
$1.91 -0.09 (-4.50%)
Closing price 04:00 PM Eastern
Extended Trading
$1.92 +0.01 (+0.52%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Sera Prognostics Stock (NASDAQ:SERA)

Advanced

Key Stats

Today's Range
$1.90
▼
$2.00
50-Day Range
$1.93
▼
$2.19
52-Week Range
$1.56
▼
$3.85
Volume
10,451 shs
Average Volume
44,497 shs
Market Capitalization
$75.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50
Consensus Rating
Moderate Buy

Company Overview

Sera Prognostics, Inc. is a women’s health company focused on identifying pregnancy risks through blood-based testing and biomarker research. The company develops diagnostic products intended to help healthcare providers assess pregnancy outcomes and support individualized care.

Its lead product, the PreTRM test, analyzes proteins in a pregnant patient’s blood to estimate the risk of spontaneous preterm birth. The company has developed the test for use by healthcare providers in the United States and continues to study its potential role in pregnancy care.

AI Generated. May Contain Errors.

Sera Prognostics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
43rd Percentile Overall Score

SERA MarketRank™: 
2.1540522438 of 5 stars

Sera Prognostics scored higher than 43% of companies evaluated by MarketBeat, and ranked 831st out of 1,706 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sera Prognostics has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 1 strong buy rating, 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    Sera Prognostics has a consensus price target of $5.50, representing about 188.0% upside from its current price of $1.91.

  • Amount of Analyst Coverage

    Sera Prognostics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Sera Prognostics' stock forecast and price target.
  • Earnings Growth

    Earnings for Sera Prognostics are expected to grow in the coming year, from ($0.62) to ($0.52) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sera Prognostics is -2.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sera Prognostics is -2.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Sera Prognostics has a P/B Ratio of 1.45. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.63% of the float of Sera Prognostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Sera Prognostics has a short interest ratio ("days to cover") of 9.12.
  • Change versus previous month

    Short interest in Sera Prognostics has recently decreased by 1.33%, indicating that investor sentiment is improving.
  • Dividend Yield

    Sera Prognostics does not currently pay a dividend.

  • Dividend Growth

    Sera Prognostics does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Sera Prognostics this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Sera Prognostics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $79,563.00 in company stock.

  • Percentage Held by Insiders

    11.30% of the stock of Sera Prognostics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    54.64% of the stock of Sera Prognostics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Sera Prognostics' insider trading history.
Receive SERA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sera Prognostics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SERA Stock News Headlines

Sera: 3 key takeaways for long-term investors
Sera Prognostics (SERA) Q3 2026 Earnings Call Transcript
Worse than socialism
Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel
See More Headlines

SERA Stock Analysis - Frequently Asked Questions

Sera Prognostics' stock was trading at $2.95 on January 1st, 2026. Since then, SERA stock has decreased by 35.3% and is now trading at $1.91.

Sera Prognostics, Inc. (NASDAQ:SERA) issued its quarterly earnings data on Wednesday, November, 4th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.14) by $0.02. The business had revenue of $42 thousand for the quarter, compared to analysts' expectations of $75 thousand. Sera Prognostics had a negative net margin of 34,866.67% and a negative trailing twelve-month return on equity of 52.54%.
Read the conference call transcript
.

Sera Prognostics (SERA) raised $75 million in an IPO on Wednesday, July 14th 2021. The company issued 4,687,500 shares at a price of $15.00-$17.00 per share.

Sera Prognostics' top institutional shareholders include Sanders Morris Harris LLC (0.80%), State Street Corp (0.32%), Empowered Funds LLC (0.13%) and Goldman Sachs Group Inc. (0.12%). Insiders that own company stock include Zhenya Lindgardt, Austin Aerts, Paul Kearney, Benjamin Jackson, John J Boniface, Tiffany Eul Davis Inglis, Robert Gardner Harrison, Dyaarl Lee Jr Anderson, Mansoor Raza Mirza, Sandra Aj Lawrence and Joshua Phillips.
View institutional ownership trends
.

Shares of SERA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sera Prognostics investors own include Aterian (ATER), Erasca (ERAS), 9 Meters Biopharma (NMTR), Orion Energy Systems (OESX), Rani Therapeutics (RANI), RxSight (RXST) and ONE Group Hospitality (STKS).

Company Calendar

Last Earnings
11/04/2026
Today
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:SERA
CIK
1534969
Fax
N/A
Employees
72
Year Founded
2008

Price Target and Rating

High Price Target
$6.00
Low Price Target
$5.00
Potential Upside/Downside
+188.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.67)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.93 million
Net Margins
-34,866.67%
Pretax Margin
-34,866.67%
Return on Equity
-52.54%
Return on Assets
-36.97%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.88
Quick Ratio
1.88

Sales & Book Value

Annual Sales
$80 thousand
Price / Sales
949.51
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.32 per share
Price / Book
1.45

Miscellaneous

Outstanding Shares
39,770,000
Free Float
35,276,000
Market Cap
$75.96 million
Optionable
Optionable
Beta
1.14

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:SERA) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners